denis Manginelli: in Sugar Land, TX

Responsible for financial, banking, legal, human resources, facilities and administration activities of a $15M+ provider of patient-specific specialty pharmacy services in the pain management, weight loss and lifestyle space. • Partnered with other senior management team members to expand product offerings and re-focus business strategy. • Lead cost reduction efforts to reorganize the company and reduce payroll by over 50%. • Negotiated payment schedules to pay outstanding trade debt liabilities. • Monitored cash flow on a weekly basis to maintain day-to-day operations during challenging period. • Moved company from cash basis accounting to GAAP accrual basis including revamping COGS accounting process. • Served as primary touch point for the company’s key partners.

Responsible for all financial, banking, legal, contracts, human resources, facilities, pricing and administrative activities of a PE owned $65M+ provider of imaging core lab and comprehensive cardiac safety and efficacy services for Phases I-IV global clinical trials. • Set up infrastructure to support business growth and diversification, which led to a company award as 3rd fasting growing company in central New Jersey and resulted in a merger with Cardiac Safety Services Company. • Reorganized business to reduce operating expenses by $11M over a 2 year period as part of a business integration and cost reduction initiative. • Directed M&A activities, including negotiations, deal structure, synergy identification, due diligence and integration for 2 successful business transactions. • Managed expense growth below rate of revenue growth leading to CAGR on EBITDA of 20% over a 5-year period and 12% over a 2-year period. • Improved financial credibility with no significant audit adjustments in 5 years and closing process reduced from 20 days to 10 days. • Facilitated Series B ($10M) and Series C ($10.7M) equity financing. • Finalist for New Jersey Technology Counsel (NJTC) “CFO of the Year” award (2008).

Responsible for all financial activities of a $200M+ Contract Research Organization (CRO) operating in 30 countries. Subsidiary of Omnicare, Inc., a $6B company and the nation’s leading provider of pharmacy services to long-term care facilities. • Reorganized business globally, reduced resources and stabilized gross margins during period of revenue decline. Margins increased by 1% while revenue decreased by 7%. • Negotiated new vendor agreements for key suppliers, with savings of $0.5M. • Reduced SG&A expenses over 10% to maintain profit margin during period of revenue decline. • Implemented new revenue/invoicing system to automate manual processes and prepare business for future growth. Reduced resources, saved $0.5M and reduced invoicing time by 3 days.